Roche R&D Spending Surge Reflects In-House Innovation, M&A Prices

‘Costs Being Squeezed Everywhere’ To Fund R&D

 
• By Sten Stovall
  
Roche's R&D Spend Has Risen Steadily In Recent Years • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D